LOP628 / Novartis  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LOP628 / Novartis
NCT02221505: Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia

Terminated
1
3
Europe, RoW
LOP628
Novartis Pharmaceuticals
cKIT-positive Solid Tumors, AML
03/15
03/15

Download Options